Targeted Skipping of a Single Exon Harboring a Premature Termination Codon Mutation: Implications and Potential for Gene Correction Therapy for Selective Dystrophic Epidermolysis Bullosa Patients-Reference-Cited by-同舟云学术

Targeted Skipping of a Single Exon Harboring a Premature Termination Codon Mutation: Implications and Potential for Gene Correction Therapy for Selective Dystrophic Epidermolysis Bullosa Patients

Published:2006-12 Issue:12 Volume:126 Page:2614-2620
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Goto Maki,Sawamura Daisuke,Nishie Wataru,Sakai Kaori,McMillan James R.,Akiyama Masashi,Shimizu Hiroshi

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference25 articles.

1. Type VII collagen, anchoring fibrils, and epidermolysis bullosa;Burgeson;J Invest Dermatol,1993

2. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa;Chen;Nat Genet,2002

3. Cloning of human type VII collagen, complete primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms;Christiano;J Biol Chem,1994

4. Structural organization of the human type VII collagen gene (COL7A1) composed of more exons than any previously characterized gene;Christiano;Genomics,1994

5. Restoration of open reading frame resulting from skipping of an exon with an internal deletion in the COL7A1 gene;Cserhalmi-Friedman;Lab Invest,1998

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging DNA & RNA editing strategies for the treatment of epidermolysis bullosa;Journal of Dermatological Treatment;2024-08-18

2. Twin Prime Editing Mediated Exon Skipping/Reinsertion for Restored Collagen VII Expression in Recessive Dystrophic Epidermolysis Bullosa;Journal of Investigative Dermatology;2024-05

3. Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa;Journal of Applied Genetics;2024-03-09

4. Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects;Therapeutics and Clinical Risk Management;2023-06

5. New RDEB intermediate variant with in-frame partial exon skipping in FN III-like domain of type VII collagen;2022-09-04